Discusses Preliminary Financial Results, Churn Impact, and Strategic Progress in Key Verticals February 3, 2026 8:00 AM ...
The FDA approved changes to the labels for six menopausal hormone therapy products in a move the agency said clarifies risk considerations for the drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results